Records containing: TP53 Gene Mutation

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2026-04-17
A Clinical Trial of Firsekibart, Tislelizumab, and Lenvatinib in Patients With Unresectable, TP53-Mutated Hepatocellular Carcinoma
CLINICAL_TRIALS study record update · 2026-04-06
Axatilimab Combined With Decitabine/Venetoclax for the Treatment of TP53-mutated/Deleted AML Patients
CLINICAL_TRIALS study record update · 2026-03-27
Li-Fraumeni & TP53: Understanding and Progress (LiFT UP)
CLINICAL_TRIALS study record update · 2026-02-19
Germline Genetic Testing of the TP53 Gene: Identification, Characterization, and Management of Patients and Families at High Risk of Cancer
CLINICAL_TRIALS study record update · 2026-01-28
A Phase I Study of a p53MVA Vaccine in Combination With Pembrolizumab
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2025-06-10
A Phase 2 Study of Oral Arsenic Trioxide (Arsenol ®)-Based Low-intensity Treatment for Previously Untreated or Relapsed/Refractory TP53-mutated Myeloid Malignancies
CLINICAL_TRIALS study record update · 2024-07-26
Translational Study of MSS, TP53 Mutation and Chromosome Instability Relationship in Endometrial Carcinoma
CLINICAL_TRIALS study record update · 2023-06-26
Post-Transplant Use of Irradiated Haplo-Allogeneic Cells
CLINICAL_TRIALS study record update · 2021-07-26
Genomic Landscape of APC, KRAS, TP53, PIK3CA, and MLH1 in Colorectal
CLINICAL_TRIALS study record update · 2021-01-22
Treatment of Patients With Metastatic Colorectal Cancer Harboring TP53 Mutations With Dose-dense Cyclophosphamide - the p53 Colorectal Cancer Trial